Skip to content

Paracetamol for Catheter Related Bladder Discomfort

THE EFFECT OF INTRAOPERATIVE PARACETAMOL ON CATHETER-RELATED BLADDER DISCOMFORT: A PROSPECTIVE, RANDOMISED, DOUBLE-BLIND STUDY

Status
Completed
Phases
Phase 4
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01652183
Enrollment
64
Registered
2012-07-27
Start date
2008-10-31
Completion date
2009-11-30
Last updated
2012-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Catheter Related Bladder Discomfort

Keywords

Intravenous paracetamol, catheter related bladder discomfort, urologic surgery

Brief summary

The insertion of an urinary catheter in a patient undergoing a surgical procedure, especially in urinary interventions, may lead to catheter-related bladder discomfort with varying degrees of severity during the postoperative period. Catheter-related bladder discomfort (CRBD) symptoms associated with indwelling urinary catheter are similar to overactive bladder symptoms such as discomfort in the suprapubic region, urinary urgency, frequency, burning sensation with or without urge incontinence. Paracetamol is a drug with proven efficiency for the management of mild and moderate postoperative pain. In this study, the investigators hypothesized to address the effect of single-dose intravenous paracetamol on postoperative CRBD following percutaneous nephrolithotomy surgery (PNL).

Interventions

Sponsors

Pinar Ergenoglu
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* ≥ 18 years of age, * American Society of Anesthesiologists (ASA) Physical Status of I-II, * undergoing PNL with urinary bladder catheter.

Exclusion criteria

* obesity (BMI \> 30), * chronic opioid use, * bladder outflow obstruction, * benign prostatic hyperplasia, and * overactive bladder (OAB) (frequency \> 3 times at night or \> 8 times within 24h).

Design outcomes

Primary

MeasureTime frameDescription
Reducing of Catheter related bladder discomfort symptomsCRBD was evaluated at postoperatively 30th minutes, 1st, 2nd, 4th, 6th and 12th hoursCRBD was evaluated with a 4 point scale (1; no discomfort, 2; mild, revealed on questioning only, 3; moderate, stated by the patient without questioning, 4; severe, urinary urgency executed by behavioral responses, such as attempts to remove urinary catheter, restless extremity movements, verbal responses) at postoperatively 30th minutes, 1st, 2nd, 4th, 6th and 12th hours.

Secondary

MeasureTime frame
Assessment of CRBD symptoms by the evaluation of VAS, sedation scales and hemodynamic findingsat postoperatively 30th minutes, 1st, 2nd, 4th, 6th and 12th hours.

Countries

Turkey (Türkiye)

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 24, 2026